Comparable stake leader
Bob Gene Gower
SEC ownership of Ensysce Biosciences, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001716947.
Disclosed value leader
A. Lorne Weil
Comparable rows
19/35
Latest evidence
30 Jun 2026
- Public ticker
- ENSC on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Bob Gene Gower
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
19 of 35
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Bob Gene Gower
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001716947
- Issuer location
- La Jolla, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Ensysce Biosciences, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bob Gene Gower
Disclosed value leader
A. Lorne Weil
Comparable rows
19/35
Latest evidence
30 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 6.1%
16 rows are not safely comparable across share classes.
13D/G row: Bob Gene Gower
Showing 1-8 of 35 holder rows.
Quick read
Bob Gene Gower leads the comparable SEC ownership view at 6.1%.
19 of 35 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bob Gene Gower's linked filing trail.
Comparable ownership
Top 5
Bob Gene Gower
6.1%
PERCEPTIVE ADVISORS LLC
3.7%
Adage Capital Management, L.P.
3.2%
Anson Funds Management LP
2.1%
JANE STREET GROUP, LLC
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 35 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bob Gene Gower |
3/4/5
13D/G
Director
|
6.1%
from 13D/G
|
$453,786
1,206,576 shares
mixed-class rows
|
+$444,169 | 23 Apr 2026 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
3.7%
|
$264,331
86,666 shares
|
$0 | 31 Mar 2025 |
| Adage Capital Management, L.P. |
13D/G
|
3.2%
|
$167,353
74,711 shares
|
$0 | 30 Jun 2025 |
| Anson Funds Management LP |
13D/G
|
2.1%
|
$209,957
411,681 shares
|
$0 | 31 Dec 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
1.1%
|
$60,561
208,833 shares
|
— | 30 Jun 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
0.76%
|
$43,416
149,711 shares
|
— | 30 Jun 2026 |
| Virtu Financial LLC |
13F
Company
|
0.48%
|
$28,000
95,391 shares
|
— | 30 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.44%
|
$24,996
86,193 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$444,169.
Buys
$444,169
Insiders: 1
Sells
$0
Insiders: 0
Net
+$444,169
Shares: +908,614
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 908,614
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 400,000 | 0 | $198,000 | $0 | +$198,000 |
| 3-6 | 508,614 | 0 | $246,169 | $0 | +$246,169 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 20 reporting-owner rows connected to Ensysce Biosciences, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
20
Largest Forms 3/4/5 holder
A. Lorne Weil
Net 12M change
+$444,169
Latest report
05 Aug 2026
Recent insider transactions for Ensysce Biosciences, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Bob G. Gower | ENSC | Common Stock | Purchase | 77.4% | $198,000 | $0.4950 | 400,000 | 916,740 | 07 Aug 2026 | Direct |
| Bob G. Gower | ENSC | Common Stock | Purchase | 6259.1% | $246,169 | $0.4840 | 508,614 | 516,740 | 23 Apr 2026 | Direct |
| Bob G. Gower | ENSC | Warrant | Conversion of derivative security | 715.8% | 254,307 | 289,836 | 23 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.